Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 249

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 249
---
 therewith, with the Securities and Exchange
Commission, granting unto such attorney-in-fact and agents full power and authority to do and perform each and every act and thing requisite
and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying
and confirming all that said attorney-in-fact and agent, or his substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities
Act of 1933, as amended, this registration statement on Form S-1 has been signed below by the following persons on behalf of the registrant
and in the capacities and on the dates indicated.

| Signature         
 /s/ Amir          
 Avraham           |     | Title                                                 
 Chief Executive Officer (Principal Executive Officer) |     | Date            
 October 3, 2025 |
|:------------------|:----|:------------------------------------------------------|:----|:----------------|
| Amir Avraham      |     |                                                       |     |                 |
| /s/ Inna          
 Martin            |     | Chief Operating Officer, President, Secretary and     
 Director                                              |     | October 3, 2025 |
| Inna Marin        |     |                                                       |     |                 |
| /s/ Arie          
 Gordashnikov      |     | Chief Financial Officer and Treasurer                 |     |                 |
| Arie Gordashnikov |     | -Principal Financial and Accounting Officer           |     | October 3, 2025 |
| /s/ Bernard       
 Bartal            |     |                                                       |     |                 |
| Bernard Bartal    |     | Chairman of the Board of Directors                    |     | October 3, 2025 |
| /s/ Matti         
 Munk              |     |                                                       |     |                 |
| Matti Munk        |     | Director                                              |     | October 3, 2025 |
| /s/ Yoram         
 Drucker           |     |                                                       |     |                 |
| Yoram Drucker     |     | Director                                              |     | October 3, 2025 |

<div align='center'>II-4

EXHIBIT INDEX</div>

| Exhibit   
 No.       
 2.1*      |     | Description                                                                                                                              
 Stock                                                                                                                                    
 Exchange Agreement by and among the Registrant, LipoVation and LipoVation’s shareholders dated November 14,